Similar tenders from other countries.
Showing 1 to 20
Procurement Of Simulation Equipment, Medical Equipment And Consumables For Simulation Equipment
16 Dec 2024
09 Jan 2025Open Procedure
Annual Public Procurement Program 2024
Framework Agreement For The Supply Of Hiv Drugs And Various Drugs
Paap 2024
Supply Of Medicines Used For The Treatment Of Neurological Diseases, Sclerosis And Hiv
Framework Agreement For Supply Of Medicines National Programs 6
Framework Agreement For The Supply Of Medicines National Programs 6
Supply Of Medicines Used For The Treatment Of Neurological Diseases, Sclerosis And Hiv
Supply of Medicine and Medical / Surgical equipments : Human Immunoglobulin for Intravenous use 1g\nvial\nNormal immunoglobulin for intravenous use BP,1g\nVial.\nEach vial to contain 1g of liquid or freeze-dried\npreparation of Normal Immunoglobulin BP for\nintravenous use.\nThe immunoglobulin should be mainly\nimmunoglobulin IgG and contain only trace\namount of IgA.\nNote:\n1.This product should be stable for 02 years when\nstored under storage condition stipulated by the\nmanufacturer.\n2.Tenderers should submit detail specification of\nthe product offered by them.\n3.The product should ensure, at least two steps of\nvirus inactivation as\nrecommended by WHO.\n4.The product should be certified as free from HIV\nand hepatitis virus.\n5.Each vial should be labelled accordingly. etc .
Annual Public Procurement Program
Paap 2024
Plan For Selecting Contractors For The Package: Providing Hall Rental Services And Related Services For The Course "Training On Guidelines For Developing Technical And Economic Norms For Medical Quarantine And Preventive Medicine Services" From November 7-8, 2024 In Hcm City Of The Global Fund For Hiv/Aids Technical Assistance Project For The Period 2024-2026 Sponsored By The Global Fund To Fight Aids, Tuberculosis And Malaria
The Annual Program Of Public Procurement For The Year 2024
Annual Public Procurement Program
Providing for for Medical Products for the ECOWAS Joint Assessment Procedure under the West Africa Medicines Regulatory Harmonization (WA-MRH)
Pharmacy Provision
Supply of Medicine and Medical / Surgical equipments : Antitetanus Human Immunoglobulin 250IU\nAmpoule/Vial/Prefilled syringe\nAntitetanus Human Immunoglobulin 250IU\nAmpoule/Vial/Prefilled syringe\nEach ampoule/vial/prefilled syringe to contain\n250IU of Antitetanus Immunoglobulin obtained\nfrom Human Plasma containing specific anti\nbodies against Clostridium tetani suitable for\nintramuscular or intravenous injection.\nNote:\n1.This injection should be stable for 24 months\nwhen stored within a temperture range of 2'C-8'C.\nDo not freeze.\n2.The manufacturer should submit a certificate for\neach batch of the product that it has been tested\nfree of Hepatitis B,Hepatitis C and HIV infections.\n3.Each ampoule/vial/prefilled syringe should be\nlabelled accordingly. etc .
Supply of Medicine and Medical / Surgical equipments : Dried Recombinant Factor VIII Fraction 200IU-\n350IU vial\nDried Recombinant Factor VIII Fraction 200IU-\n350IU vial\nDried factor VIII Fraction BP (Dried Recombinant\nAntihaemophilic Fraction) 200IU-350IU vial\nOR\nRecombinant Coagulation Factor VIII Ph Eur.\n200IU-350IU vial\nOR\nRecombinant Antihemophilic Factor USP 200IU-\n350IU vial\nOR\nDried Recombinant Antihaemophilic Fraction\nIP200IU-350IU vial\nEach vial to contain 200IU-350IU of concentrated,\npurified and viruses inactivated 3rd or 4th\ngeneration recombinant dried factor VIII Fraction\nBP, Ph Eur, USP or IP.\nNote:\n1. The item should be stable at temperature 2oC –\n8oC.\n2. The product should have minimum 24 months\nshelf life at the time of delivery to MSD.\n3. Tenderer should submit detailed specifications\nof the product offered.\n4. The product should ensure, at least two steps on\nvirus inactivation as recommended by\nWHO/US.FDA\n5. The purification process should be specified by\nthe manufacturer.\n6. Each batch should be certified as free from HIV\nhepatitis and other viruses.\n7. Anti viral test methods used for screening for\nHIV and Hepatitis viruses should be declared by\nthe manufacturer. The test methods used should\nbe approved by WHO/US.FDA.\n8. Each vial to be supplied with suitable diluent.\n9. The product should be protected from light. etc .
Didaclibros Ltda
Tenders by Country